Dr Saskia van Hemert PhD has been conducting research into the mechanisms of action and clinical applications of specific probiotics. She has co-authored more than 30 research articles and has been working on probiotic trials for neuropsychiatric conditions, migraine, Inflammatory Bowel Disease, allergies and cardiometabolic health. Saskia will share her experience and expert understanding of probiotic therapy which can easily be incorporated into your patient management.
Changes in the gut microbiota and reduction in the intestinal barrier function are linked to the pathogenesis of many diseases. Gut barrier damage facilitates passage of a variety of compounds including lipopolysaccharides (LPS) to the portal circulation causing systemic inflammation and immune activation. Furthermore, alterations in gut microbiota are linked to the development of several metabolic and immune disorders highlighting the powerful impact of the gut environment on our health.
Selected probiotics exert their beneficial effects via inhibiting pathogenic bacteria, decreasing inflammation, strengthening gut barrier integrity, and reducing the systemic LPS burden. Specific probiotic interventions can be used to reinforce the intestinal barrier to prevent disease development.
In this webinar, Saskia will share:
- The importance of gut barrier function and the role of the gut microbiota in health and disease
- Evidence to illustrate the proposed mechanisms underpinning the gut-brain-axis and the neuropsychiatric impact of a dysregulated gut barrier
- Demonstrated links between GIT barrier dysfunction and inflammatory and neurological disease
- Review of clinical trials investigating the effect of specific probiotics on the gut-brain axis
- How to utilise targeted probiotic therapy to improve gastrointestinal barrier function and integrity to support a variety patient health concerns
Materials available include:
- Video Recordings
- Audio Recordings
- Digital Notes and Resources
- CPE Certificate of Attendance (1.5 Contact Hours)